These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
219 related articles for article (PubMed ID: 37219057)
1. Retraction statement: Wu, H., He, Y., Chen, H., Liu, Y., Wei, B., Chen, G., Lin, H. and Lin, H. (2019), LncRNA THOR increases osteosarcoma cell stemness and migration by enhancing SOX9 mRNA stability. FEBS Open Bio, 9: 781-790. FEBS Open Bio; 2023 Aug; 13(8):1539. PubMed ID: 37219057 [TBL] [Abstract][Full Text] [Related]
2. Retraction statement: Shao, L., Zhang, X. and Yao, Q. (2020), The F-box protein FBXO11 restrains hepatocellular carcinoma stemness via promotion of ubiquitin-mediated degradation of Snail. FEBS Open Bio, 10: 1810-1820. FEBS Open Bio; 2023 Aug; 13(8):1537. PubMed ID: 37219054 [TBL] [Abstract][Full Text] [Related]
3. Retraction statement: Long noncoding RNA MALAT1 promotes the stemness of esophageal squamous cell carcinoma by enhancing YAP transcriptional activity. FEBS Open Bio, 9: 1392-1402. FEBS Open Bio; 2023 Nov; 13(11):2158. PubMed ID: 37792303 [TBL] [Abstract][Full Text] [Related]
4. Retraction statement: Yiwen Xiao, Jingjing Pan, Qian Geng, Ge Wang (2019), LncRNA MALAT1 increases the stemness of gastric cancer cells via enhancing SOX2 mRNA stability. FEBS Open Bio, 9: 1212-1222. FEBS Open Bio; 2023 Sep; 13(10):1986. PubMed ID: 37724913 [TBL] [Abstract][Full Text] [Related]
5. Retraction statement: Ding, J., Wang, X., Gao, J. and Song, T. (2021), Silencing of cystatin SN abrogates cancer progression and stem cell properties in papillary thyroid carcinoma. FEBS Open Bio, 11: 2186-2197. FEBS Open Bio; 2023 Aug; 13(8):1540. PubMed ID: 37410095 [TBL] [Abstract][Full Text] [Related]
6. Retraction statement: Dai, Y., Xie, F. and Chen, Y. (2020), Reduced levels of miR-485-5p in HPV-infected cervical cancer promote cell proliferation and enhance invasion ability. FEBS Open Bio, 10: 1348-1361. FEBS Open Bio; 2023 Aug; 13(8):1538. PubMed ID: 37219053 [TBL] [Abstract][Full Text] [Related]
7. Retraction: Kinesin family member 3A stimulates cell proliferation, migration, and invasion of bladder cancer cells in vitro and in vivo. FEBS Open Bio; 2024 Mar; 14(3):528. PubMed ID: 38149473 [TBL] [Abstract][Full Text] [Related]
8. Retraction statement: Long non-coding RNA PGM5-AS1 promotes epithelial-mesenchymal transition, invasion and metastasis of osteosarcoma cells by impairing miR-140-5p-mediated FBN1 inhibition. Mol Oncol; 2023 Aug; 17(8):1692. PubMed ID: 37471281 [TBL] [Abstract][Full Text] [Related]
9. Retraction: Wang C, Chen Z, Ge Q, Hu J, Li F, Hu J, Xu H, Ye Z, Li LC (2014) Up-regulation of p21 FEBS Lett; 2024 Jun; 598(11):1449. PubMed ID: 38747074 [TBL] [Abstract][Full Text] [Related]
10. RETRACTION: The long noncoding RNA AK002107 negatively modulates miR-140-5p and targets TGFBR1 to induce epithelial-mesenchymal transition in hepatocellular carcinoma. Mol Oncol; 2024 Aug; 18(8):2062. PubMed ID: 38873938 [TBL] [Abstract][Full Text] [Related]
11. RETRACTION: MeCP2 Drives Hepatocellular Carcinoma Progression Via Enforcing HOXD3 Promoter Methylation and Expression Through the HB-EGF/EGFR Pathway. Mol Oncol; 2024 Aug; 18(8):2061. PubMed ID: 38837853 [TBL] [Abstract][Full Text] [Related]
12. Withdrawal statement: [Liu, X., Qiao, L., Zhang, H., Zhang, C., Ding, R., Kang, J., Liu, Y., Lin, J. and Yan, X. (2023), Argonaute 2 regulates LPS-induced inflammation in microglial BV2 cells by targeting Cadm1. FEBS Open Bio. Accepted Author Manuscript]. FEBS Open Bio; 2023 Aug; 13(8):1536. PubMed ID: 37014310 [TBL] [Abstract][Full Text] [Related]
13. RETRACTION: Selection for TRAIL Resistance Results in Melanoma Cells with High Proliferative Potential. FEBS Lett; 2024 Oct; 598(20):2615. PubMed ID: 39334560 [TBL] [Abstract][Full Text] [Related]
14. RETRACTION: Long Non Coding RNA SLC26A4-AS1 Exerts Antiangiogenic Effects in Human Glioma by Upregulating NPTX1 Via NFKB1 Transcriptional Factor. FEBS J; 2024 Oct; 291(20):4633. PubMed ID: 39348167 [TBL] [Abstract][Full Text] [Related]
15. Retraction: The long non-coding RNA-ROR promotes osteosarcoma progression by targeting miR-206. J Cell Mol Med; 2024 Mar; 28(6):e18199. PubMed ID: 38439141 [TBL] [Abstract][Full Text] [Related]
16. Retraction Statement: Circ-TCF4.85 silencing inhibits cancer progression through microRNA-486-5p-targeted inhibition of ABCF2 in hepatocellular carcinoma. Mol Oncol; 2023 Jul; 17(7):1453. PubMed ID: 37231579 [TBL] [Abstract][Full Text] [Related]
17. RETRACTION: CircRNA EPHB4 modulates stem properties and proliferation of gliomas via sponging miR-637 and up-regulating SOX10. Mol Oncol; 2024 Oct; 18(10):2603. PubMed ID: 38952175 [TBL] [Abstract][Full Text] [Related]
18. RETRACTION: Repression of CRNDE Enhances the Anti-Tumour Activity of CD8 + T Cells Against Oral Squamous Cell Carcinoma Through Regulating Mir-545-5p and TIM-3. J Cell Mol Med; 2024 Aug; 28(15):e18566. PubMed ID: 39109524 [TBL] [Abstract][Full Text] [Related]
19. RETRACTION: Exosomal miR-106a-5p Accelerates the Progression of Nasopharyngeal Carcinoma Through FBXW7-Mediated TRIM24 Degradation. Cancer Sci; 2024 Nov; 115(11):3829. PubMed ID: 39166827 [TBL] [Abstract][Full Text] [Related]